EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F

Elayoni E Igomu iD, Paul H Mamman, Jibril Adamu iD, Maryam Muhammad, Abubarkar O Woziri iD, Manasa Y Sugun, John A Benshak, Kingsley C Anyika, Rhoda Sam-Gyang, David O Ehizibolo

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0306200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Elayoni E Igomu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bacterial Vaccine Production Department, National Veterinary Research Institute, Vom, Plateau State, Nigeria. Hauptthemen laut MEDLINE: Epitopes, T-Lymphocyte, Salmonella Infections, Computational Biology, Salmonella Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global public health risk posed by Salmonella Kentucky ( S . Kentucky) is rising, particularly due to the dissemination of antimicrobial resistance genes in human and animal populations. This serovar, widespread in Africa, has emerged as a notable cause of non-typhoidal gastroenteritis in humans. In this study, we used a bioinformatics approach to develop a peptide-based vaccine targeting epitopes from the outer membrane proteins A, C, and F of S . Kentucky. Additionally, we employed flagellin protein ( fliC ) from Salmonella Typhimurium ( S . Typhimurium) as an adjuvant to enhance the vaccine’s effectiveness. Through this approach, we identified 14 CD8+ and 7 CD4+ T-cell epitopes, which are predicted to be restricted by various MHC class I and MHC class II alleles. The predicted epitopes are expected to achieve a population coverage of 94.91% when used in vaccine formulations. Furthermore, we identified seven highly immunogenic linear B-cell epitopes and three conformational B-cell epitopes. These T-cell and B-cell epitopes were then linked using appropriate linkers to create a multi-epitope vaccine (MEV). To boost the immunogenicity of the peptide construct, fliC from S . Typhimurium was included at the N-terminal. The resulting MEV construct demonstrated high structural quality and favorable physicochemical properties. Molecular docking studies with Toll-like receptors 1, 2, 4, and 5, followed by molecular dynamic simulations, suggested that the vaccine-receptor complexes are energetically feasible, stable, and robust. Immune simulation results showed that the MEV elicited significant responses, including IgG, IgM, CD8+ T-cells, CD4+ T-cells, and various cytokines (IFN-γ, TGF-β, IL-2, IL-10, and IL-12), along with a noticeable reduction in antigen levels. Despite these promising in-silico findings, further validation through preclinical and clinical trials is required to confirm the vaccine’s efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epitopes, T-LymphocyteSalmonella InfectionsComputational BiologySalmonella VaccinesBacterial Outer Membrane ProteinsHumansEpitopes, B-LymphocyteMolecular Docking SimulationFlagellinSalmonella typhimuriumCD8-Positive T-LymphocytesVaccines, SubunitAnimalsImmunoinformatics

Substanzen

Epitopes, T-LymphocyteSalmonella VaccinesBacterial Outer Membrane ProteinsEpitopes, B-LymphocyteFlagellinVaccines, Subunit

Autor:innen und Institutionen

  • Bacterial Vaccine Production Department, National Veterinary Research Institute, Vom, Plateau State, Nigeria.
  • Department of Veterinary Microbiology, Ahmadu Bello University, Zaria, Kaduna State, Nigeria.
  • Bacterial Research Department, National Veterinary Research Institute, Vom, Plateau State, Nigeria.
  • Biotechnology Center, National Veterinary Research Institute, Vom, Plateau State, Nigeria.
  • Foot and Mouth Disease Department, National Veterinary Research Institute, Vom, Plateau State, Nigeria.

ORCID-Profile: Elayoni E Igomu, Jibril Adamu, Abubarkar O Woziri

Zitieren

APA

Igomu, E. E., Mamman, P. H., Adamu, J., Muhammad, M., Woziri, A. O., Sugun, M. Y., Benshak, J. A., Anyika, K. C., Sam-Gyang, R., & Ehizibolo, D. O. (2025). Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F. PLOS ONE. https://doi.org/10.1371/journal.pone.0306200

Vancouver

Igomu EE, Mamman PH, Adamu J, Muhammad M, Woziri AO, Sugun MY, et al. Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F. PLOS ONE. 2025. doi:10.1371/journal.pone.0306200

BibTeX
@article{Igomu2025,
  author = {Igomu, Elayoni E and Mamman, Paul H and Adamu, Jibril and Muhammad, Maryam and Woziri, Abubarkar O and Sugun, Manasa Y and Benshak, John A and Anyika, Kingsley C and Sam-Gyang, Rhoda and Ehizibolo, David O},
  title = {Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0306200}
}
Kostenlos starten →